InduPro
Christopher May is a Scientist II at InduPro since April 2022, previously serving as a Scientist I. Prior experience includes a role as Scientist II (Associate) at Merck from November 2020 to April 2022, and as a Postdoctoral Associate in the lab of Dr. James Hansen at Yale University School of Medicine, where research focused on the effects of autoantibodies on nuclear processes related to autoimmune disease and cancer therapeutics. Christopher completed a PhD in Cell Biology at Yale University, where responsibilities included serving as a Graduate Teaching Fellow. Prior to that, a Postbaccalaureate Researcher at the National Institute of Diabetes and Digestive and Kidney Diseases conducted research on nuclear shape in budding yeast. Academic qualifications include a BS in Biological Sciences from Carnegie Mellon University.
This person is not in any offices
InduPro
InduPro is bringing life-changing therapies to patients through novel cell-surface platform technologies. We are defining and manipulating protein interactions beyond natural signaling paradigms. InduPro platforms, integrate inherent protein proximity at the cell surface with the ability to manipulate protein pairings via induced protein proximity to create novel signaling pathways and logic gates.